CJC-1295 and Ipamorelin Explained: What They Are and How They’re Regulated

CJC-1295 and Ipamorelin are two distinct peptides that are frequently discussed together. This article covers what class of substances they are, their research history, and how they’re regulated in Australia — for general educational purposes only.

---

What Are CJC-1295 and Ipamorelin?

CJC-1295 and Ipamorelin are synthetic peptides, often discussed together because of overlapping research interest, though they are distinct molecules studied separately in the research literature. Research into both includes laboratory, animal, and some early-phase human studies internationally, though the depth and quality of human evidence varies. Neither is an approved medicine in Australia.

---

Regulatory Status in Australia

CJC-1295 and Ipamorelin are not listed on the Australian Register of Therapeutic Goods (ARTG) as approved medicines. They have not been evaluated by the Therapeutic Goods Administration (TGA) for safety, quality, or effectiveness, and they are not available for general retail sale.

Where an appropriately qualified, registered healthcare practitioner considers a compounded preparation clinically appropriate for an individual patient — based on their own independent clinical judgement — it may be prescribed and dispensed through a licensed Australian compounding pharmacy. This is an individual clinical decision, not a general approval or endorsement of these substances.

---

Why Individual Assessment Matters

Because these peptides are not approved, standardised therapeutic goods, any decision about whether a compounded preparation might be appropriate rests entirely with an independent, registered healthcare practitioner, following a review of the individual’s medical history, current medications, and circumstances. Not every individual will be considered suitable, and a consultation does not guarantee that any prescription will be issued.

---

Common Questions

Are CJC-1295 and Ipamorelin approved for use in Australia?
No. Neither is listed on the ARTG. Any access occurs only through individual prescription and compounding, at the discretion of a registered practitioner.

Can I buy them directly?
No reputable, legal pathway allows direct-to-consumer sale of these peptides as therapeutic goods in Australia.

What does the current research show?
Evidence includes some early-phase human research internationally alongside laboratory and animal studies, but the overall body of evidence remains limited compared to established, ARTG-approved medicines. No conclusions about effectiveness or safety should be drawn from this stage of research alone.

---

Disclaimer

This article is for general educational purposes only and does not constitute medical advice, and is not a representation that CJC-1295 or Ipamorelin are safe, effective, or approved for any purpose. It is not intended to promote the use, purchase, or supply of any therapeutic good.

GL Vitality Drips operates as a consultation coordination and administrative support service only and does not provide, supply, or grant access to any therapeutic good. GL Vitality Drips does not diagnose, treat, or prescribe. All clinical decisions are made independently by appropriately qualified, registered healthcare practitioners following individual consultation and assessment. Not every individual will be considered a suitable candidate, and no outcome is guaranteed.

Where a prescription is issued, preparation occurs through a licensed Australian compounding pharmacy in accordance with applicable Australian laws and professional standards.